COVID-19肺炎清醒俯卧位患者选择的理论依据与意义
本文针对Ng等关于COVID-19肺炎清醒俯卧位的研究通讯提出商榷,认为COVID-19临床表现、严重程度和轨迹存在表型多样性,治疗如清醒俯卧位应基于主要病理生理和免疫病理进行个体化选择,在得出俯卧位疗效结论前需解决若干关键问题。
要点
- COVID-19在临床表现、严重程度和轨迹上呈表型多样性
- 治疗应基于主要病理生理和免疫病理进行个体化选择
- 肯定清醒俯卧位安全可行,但疗效结论前需解决患者选择等关键问题
核心结论
- COVID-19肺炎清醒俯卧位的疗效结论需在解决患者选择等关键问题后得出。
研究设计与样本
- 本文为针对Ng等关于COVID-19肺炎清醒俯卧位研究通讯的读者来信。
主要发现
- Ng等描述清醒俯卧位经验并结论该操作可延迟或减少重症监护需求。
- 来信认可该操作在COVID-19肺炎患者中的安全性和可行性。
- 来信指出在得出俯卧位疗效结论前需解决若干关键点。
临床怎么用
- 对COVID-19肺炎患者实施清醒俯卧位应基于主要病理生理和免疫病理进行个体化选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
COVID-19 is increasingly recognised to manifest phenotypic diversity in clinical presentation, severity and trajectory. As such, treatment, e.g. awake prone positioning, should be personalised and guided by the primary pathophysiology and immunopathology. https://bit.ly/2ZneHlF We read with interest the research letter by Ng et al. [1], which described their experience in prone positioning (PP) for awake patients with coronavirus disease 2019 (COVID-19) pneumonia, and concluded that this manoeuvre could delay or reduce the need for intensive care. We agree that the authors demonstrated safety and feasibility of PP in COVID-19 pneumonia patients. However, we humbly suggest a few crucial points be addressed before drawing conclusions on the efficacy of PP.
引用
- Huang CF, Tay CK, Zhuang YF, et al. Rationale and significance of patient selection in awake prone positioning for COVID-19 pneumonia. Eur Respir J. 2020. PMID: 32631837. doi:10.1183/13993003.02173-2020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。